These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11509086)

  • 1. Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial.
    Feigin VL; Doronin BM; Popova TF; Gribatcheva EV; Tchervov DV
    Eur J Neurol; 2001 Jan; 8(1):81-5. PubMed ID: 11509086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.
    Hill MD; Goyal M; Menon BK; Nogueira RG; McTaggart RA; Demchuk AM; Poppe AY; Buck BH; Field TS; Dowlatshahi D; van Adel BA; Swartz RH; Shah RA; Sauvageau E; Zerna C; Ospel JM; Joshi M; Almekhlafi MA; Ryckborst KJ; Lowerison MW; Heard K; Garman D; Haussen D; Cutting SM; Coutts SB; Roy D; Rempel JL; Rohr AC; Iancu D; Sahlas DJ; Yu AYX; Devlin TG; Hanel RA; Puetz V; Silver FL; Campbell BCV; Chapot R; Teitelbaum J; Mandzia JL; Kleinig TJ; Turkel-Parrella D; Heck D; Kelly ME; Bharatha A; Bang OY; Jadhav A; Gupta R; Frei DF; Tarpley JW; McDougall CG; Holmin S; Rha JH; Puri AS; Camden MC; Thomalla G; Choe H; Phillips SJ; Schindler JL; Thornton J; Nagel S; Heo JH; Sohn SI; Psychogios MN; Budzik RF; Starkman S; Martin CO; Burns PA; Murphy S; Lopez GA; English J; Tymianski M;
    Lancet; 2020 Mar; 395(10227):878-887. PubMed ID: 32087818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A
    Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinpocetine for acute ischaemic stroke.
    Bereczki D; Fekete I
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD000480. PubMed ID: 18253980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinpocetine for acute ischaemic stroke.
    Bereczki D; Fekete I
    Cochrane Database Syst Rev; 2000; (2):CD000480. PubMed ID: 10796369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study.
    Nader-Kawachi J; Góngora-Rivera F; Santos-Zambrano J; Calzada P; Ríos C
    Neurol Res; 2007 Apr; 29(3):331-4. PubMed ID: 17509235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.
    Zhang F; Yan C; Wei C; Yao Y; Ma X; Gong Z; Liu S; Zang D; Chen J; Shi FD; Hao J
    Transl Stroke Res; 2018 Apr; 9(2):174-184. PubMed ID: 28691141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Elkins J; Veltkamp R; Montaner J; Johnston SC; Singhal AB; Becker K; Lansberg MG; Tang W; Chang I; Muralidharan K; Gheuens S; Mehta L; Elkind MSV
    Lancet Neurol; 2017 Mar; 16(3):217-226. PubMed ID: 28229893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
    Palesch YY; Hill MD; Ryckborst KJ; Tamariz D; Ginsberg MD
    Stroke; 2006 Aug; 37(8):2107-14. PubMed ID: 16809570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.
    Zhang W; Huang Y; Li Y; Tan L; Nao J; Hu H; Zhang J; Li C; Kong Y; Song Y
    Clin Drug Investig; 2016 Sep; 36(9):697-704. PubMed ID: 27283947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Panda PK; Ramachandran A; Panda P; Sharawat IK
    Neurocrit Care; 2022 Aug; 37(1):314-325. PubMed ID: 35488169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
    Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A
    Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
    Diener HC
    Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke].
    Belova LA; Mashin VV; Proshin AN; Ovsyannicova AN; Kostishko BB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):51-58. PubMed ID: 29053121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
    Bagoly E; Fehér G; Szapáry L
    Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.
    Bornstein NM; Saver JL; Diener HC; Gorelick PB; Shuaib A; Solberg Y; Thackeray L; Savic M; Janelidze T; Zarqua N; Yarnitsky D; Molina CA;
    Lancet; 2019 Jul; 394(10194):219-229. PubMed ID: 31133406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.